Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1982 Apr;15(4):684–687. doi: 10.1128/jcm.15.4.684-687.1982

Evaluation of fluorescent antinuclear antibody assays, Crithidia luciliae substrate, and single-stranded DNA-binding capacity in diagnosis of four rheumatic diseases.

M Chiang, D Chia, E V Barnett
PMCID: PMC272167  PMID: 7040465

Abstract

Sera from groups of patient with systemic lupus erythematosus, mixed connective tissue disease, rheumatoid arthritis, and progressive systemic sclerosis and normal controls were compared, using different antinuclear antibody assays. Hep-II cells, used as a substrate for the detection of antinuclear antibodies, appeared to be more sensitive than rat liver substrate. In addition, the fluorescent patterns were easier to identify on Hep-II cells. All systemic lupus erythematosus sera with antibodies reactive with kinetoplasts of Crithidia luciliae had binding greater than 43% for single-stranded DNA. Based on the high sensitivity of the Hep-II substrate and the relative specificity of high (greater than 43%) binding for single stranded DNA by sera from patients with systemic lupus erythematosus, it appears that these two tests are most useful in differential diagnosis and for the detection of systemic lupus erythematosus.

Full text

PDF
684

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., Lakmaker F., De Groot E. R. Immunology of DNA. IV. Quantitative aspects of the Farr assay. J Immunol Methods. 1976;11(2):153–163. doi: 10.1016/0022-1759(76)90143-5. [DOI] [PubMed] [Google Scholar]
  2. Aarden L. A., Lakmaker F., de Groot E. R., Swaak A. J., Feltkamp T. E. Detection of antibodies to DNA by radioimmunoassay and immunofluorescence. Scand J Rheumatol Suppl. 1975;11:12–19. doi: 10.3109/03009747509095624. [DOI] [PubMed] [Google Scholar]
  3. Ballou S. P., Kushner I. Anti-native DNA detection by the Crithidia luciliae method: an improved guide to the diagnosis and clinical management of systemic lupus erythematosus. Arthritis Rheum. 1979 Apr;22(4):321–327. doi: 10.1002/art.1780220402. [DOI] [PubMed] [Google Scholar]
  4. Barnett E. V. The role of DNA structure in determining the sensitivity and specificity of anti-DNA antibody tests. J Rheumatol. 1978 Winter;5(4):363–364. [PubMed] [Google Scholar]
  5. Bell C., Talal N., Schur P. H. Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Arthritis Rheum. 1975 Nov-Dec;18(6):535–540. doi: 10.1002/art.1780180602. [DOI] [PubMed] [Google Scholar]
  6. Friou G. J. Double-stranded DNA: an antigen of unique significance. J Lab Clin Med. 1978 Apr;91(4):545–549. [PubMed] [Google Scholar]
  7. Johnson G. D., Edmonds J. P., Holborow E. J. Precipitating antibody to D.N.A. detected by two-stage electroimmunodiffusion. Study in S.L.E. and in rheumatoid arthritis. Lancet. 1973 Oct 20;2(7834):883–885. doi: 10.1016/s0140-6736(73)92008-4. [DOI] [PubMed] [Google Scholar]
  8. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  9. Slater N. G., Cameron J. S., Lessof M. H. The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus. Clin Exp Immunol. 1976 Sep;25(3):480–486. [PMC free article] [PubMed] [Google Scholar]
  10. Stollar B. D., Papalian M. Secondary structure in denatured DNA is responsible for its reaction with antinative DNA antibodies of systemic lupus erythematosus sera. J Clin Invest. 1980 Aug;66(2):210–219. doi: 10.1172/JCI109846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tan E. M., Rodnan G. P., Garcia I., Moroi Y., Fritzler M. J., Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 1980 Jun;23(6):617–625. doi: 10.1002/art.1780230602. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES